Nutriband inc.NTRB.US Overview
NTRB Overall Performance
NTRB AI Analysis & Strategy
NTRB Recent Performance
-0.96%
Nutriband inc.
0.81%
Avg of Sector
-1.14%
S&P500
NTRB PowerScanner
NTRB Key Information
NTRB Valuation Metrics
NTRB Earnings Table
NTRB Profile
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. Nutriband Inc. has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices. The company was incorporated in 2016 and is headquartered in Orlando, Florida.